PFIZER INC Restructuring and Related Cost, Expected Number of Positions Eliminated
PFIZER INC (PFE) reported Restructuring and Related Cost, Expected Number of Positions Eliminated of 150 Employee for the 3-month period ending 2017-04-02, per its 10-Q filed 2017-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated · last filed 2017-05-11
- PFIZER INC restructuring and related cost, expected number of positions eliminated for the quarter ending 2017-04-02 was 150.00 Employee, a 50.00% increase year-over-year.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for the quarter ending 2016-04-03 was 100.00 Employee, a 50.00% decline year-over-year.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for the quarter ending 2015-03-29 was 200.00 Employee, a 0.00% change year-over-year.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for the quarter ending 2014-03-30 was 200.00 Employee.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for fiscal 2016 was 4.90K Employee, a 25.64% increase from fiscal 2015.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for fiscal 2015 was 3.90K Employee, a 129.41% increase from fiscal 2014.
- PFIZER INC restructuring and related cost, expected number of positions eliminated for fiscal 2014 was 1.70K Employee.
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 3 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 12 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 108 month |
|---|---|---|---|---|---|
| 2017-04-02 | 150.00 Employee 10-Q · filed 2017-05-11 | ||||
| 2016-12-31 | 4.90K Employee 10-K · filed 2017-02-23 | ||||
| 2016-10-02 | 2.10K Employee 10-Q · filed 2016-11-10 | ||||
| 2016-07-03 | 600.00 Employee 10-Q · filed 2016-08-11 | ||||
| 2016-04-03 | 100.00 Employee 10-Q · filed 2016-05-12 | ||||
| 2015-12-31 | 3.90K Employee 10-K · filed 2016-02-29 | ||||
| 2015-09-27 | 2.50K Employee 10-Q · filed 2015-11-05 | ||||
| 2015-06-28 | 500.00 Employee 10-Q · filed 2015-08-06 | ||||
| 2015-03-29 | 200.00 Employee 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | 1.70K Employee 10-K · filed 2015-02-27 | ||||
| 2014-09-28 | 100.00 Employee 10-Q · filed 2014-11-06 | ||||
| 2014-06-29 | 300.00 Employee 10-Q · filed 2014-08-07 | ||||
| 2014-03-30 | 200.00 Employee 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | 65.10K Employee 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |